Michael Dambach
Treasurer presso BIOGEN INC.
Profilo
Michael E.
Dambach is currently the Treasurer, Director & Vice President at Stromedix, Inc. He also holds the position of Treasurer & Vice President at Biogen, Inc. since 2010.
Previously, he served as Treasurer & Director at Bioverativ Therapeutics, Inc. and as an Independent Director at BiomX, Inc. from 2023 to 2024.
He also worked as an Assistant Treasurer at Thermo Fisher Scientific, Inc. Mr. Dambach holds an MBA from Boston University and an undergraduate degree from the University of New Hampshire.
Posizioni attive di Michael Dambach
| Società | Posizione | Inizio |
|---|---|---|
| BIOGEN INC. | Treasurer | 01/01/2010 |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Michael Dambach
| Società | Posizione | Fine |
|---|---|---|
| BIOMX INC. | Direttore/Membro del Consiglio | 15/03/2024 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | - |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
Formazione di Michael Dambach
| University of New Hampshire | Undergraduate Degree |
| Boston University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| BIOMX INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| Aziende private | 2 |
|---|---|
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Stromedix, Inc.
Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael Dambach